1. Catalog
  2. WCLC 2025 - Posters & ePosters
  3. P3.12.74 IMM2510, an Anti-PD-L1/VEGF Bispecific An ...
P3.12.74 IMM2510, an Anti-PD-L1/VEGF Bispecific Antibody Fusion Protein for Advanced IO-treated SQ-NSCLC: A Phase I Study
Back to course
Asset Subtitle
Deqiang Jing
Meta Tag
Speaker Deqiang Jing
Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy
Powered By